Skip to main content

Sjögren’s Syndrome in Israel: A Scientific Point of View

  • Chapter
  • First Online:
Sjögren’s Syndrome
  • 1475 Accesses

Abstract

The knowledge about primary and secondary Sjögren’s syndrome in Israel is well established by physicians of all specialties. Studies from Israel have dealt with both clinical and scientific patterns of the disease. Many studies have been published exploring the various inflammatory markers both in the saliva and in the tear fluid trying to assess disease activity. Studies on the prevalence of various autoantibodies in this disease and their similarity to other autoimmune disorders shed more light on the concept of “the mosaic of autoimmunity.”

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Assessment of the European classification criteria for Sjögren’s syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren’s Syndrome. Ann Rheum Dis. 1996;55(2):116–21.

    Article  PubMed  CAS  Google Scholar 

  2. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjögren’s syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993;36:340–7.

    Google Scholar 

  3. Tishler M, Alosachie I, Barka N, et al. Primary Sjögren’s syndrome and primary biliary cirrhosis: differences and similarities in the autoantibody profile. Clin Exp Rheumatol. 1995;(4):497–500.

    Google Scholar 

  4. Tishler M, Barak Y, Paran D, Yaron M. Sleep disturbances, fibromyalgia and primary Sjögren’s syndrome. Clin Exp Rheumatol. 1997;5(1):71–4.

    Google Scholar 

  5. Tishler M, Paran D, Yaron M. Allergic disorders in primary Sjögren’s syndrome. Scand J Rheumatol. 1998;27(3):166–9.

    Article  PubMed  CAS  Google Scholar 

  6. Tishler M, Yaron I, Raz A, Meyer FA, Yaron M. Salivary eicosanoid concentration in patients with Sjögren’s syndrome. Ann Rheum Dis. 1996;55(3):202–4.

    Article  PubMed  CAS  Google Scholar 

  7. Tishler M, Yaron I, Shirazi I, Yaron M. Salivary and serum hyaluronic acid concentrations in patients with Sjögren’s syndrome. Ann Rheum Dis. 1998;57(8):506–508.

    Article  PubMed  CAS  Google Scholar 

  8. Tishler M, Yaron I, Geyer O, Shirazi I, Naftaliev E, Yaron M. Elevated tear interleukin-6 levels in patients with Sjögren syndrome. Ophthalmology 1998;105(12):2327–29.

    Article  PubMed  CAS  Google Scholar 

  9. Tishler M, Yaron I, Shirazi I, Yossipov Y, Yaron M. Increased salivary interleukin-6 levels in patients with primary Sjögren’s syndrome. Rheumatol Int. 1999;18(4):125–7.

    Article  PubMed  CAS  Google Scholar 

  10. Tishler M, Yaron I, Shirazi I, Levartovsky D, Yaron M. Salivary and serum soluble interleukin-2 receptor in primary Sjögren’s syndrome. Arch Oral Biol. 1999;44(4):305–8.

    Article  PubMed  CAS  Google Scholar 

  11. Shoenfeld Y. Experimental and induced animal models of SLE and Sjögren’s syndrome. Curr Opin Rheumatol. 1989;1:360–8.

    Article  PubMed  CAS  Google Scholar 

  12. Maran R, Dueymes M, Pennec YL, Casburn-Budd R, Shoenfeld Y, Youinou P. Predominance of IgG subclass of anti-λ(rho)/SS-A, but not anti-λ(lambda)/S-B antibodies in primary Sjögren’s syndrome. J Autoimmunity. 1993;6:379–87.

    Article  CAS  Google Scholar 

  13. Levy Y, Dueymes M, Pennec YL, Shoenfeld Y, Youinou P. IgA in Sjögren’s syndrome. Clin Exp Rheumatol. 1994;12:543–51.

    PubMed  CAS  Google Scholar 

  14. Tishler M, Alosachie I, Barak N, et al. Primary Sjögren’s syndrome and primary biliary cirrhosis: differences and similarities in the autoantibody profile. Clin Exp Rheumatol. 1995;13:497–500.

    PubMed  CAS  Google Scholar 

  15. Shoenfeld Y, Zandman-Goddard G, Stojanovich L, et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases—2008. IMAJ 2008;10:8–12.

    PubMed  Google Scholar 

  16. Shoenfeld Y, Blank M, Abu-Shakra M, et al. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases—2008. IMAJ 2008;10:13–9.

    PubMed  Google Scholar 

  17. Tishler M, Yaron I, Shirazi I, Yaron M. Hydroxychloroquine treatment for primary Sjögren’s syndrome: its effect on salivary and serum inflammatory markers. Ann Rheum Dis. 1999;58(4):253–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Moshe Tishler .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Tishler, M., Shoenfeld, Y. (2011). Sjögren’s Syndrome in Israel: A Scientific Point of View. In: Fox, R., Fox, C. (eds) Sjögren’s Syndrome. Springer, New York, NY. https://doi.org/10.1007/978-1-60327-957-4_29

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-957-4_29

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-60327-956-7

  • Online ISBN: 978-1-60327-957-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics